SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 5 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Caps

How do you think SCLN will perform against the market?

Add Stock to CAPS Watchlist

All Players

168 Outperform
12 Underperform
 

All-Star Players

21 Outperform
2 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top SCLN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Nightshaded (21.47)
Submitted May 13, 2011

This biotech, I mean volcano, is beginning to smoke. First I highly recommend doing YOUR OWN research, I can't express this enough. Do not base your decisions from what myself or some total stranger claims, which could be tainted with hidden motives… More

zzlangerhans (99.81)
Submitted May 11, 2011

Seems like SciClone's share price keeps gravitating back up towards 5, despite unpredictability of future revenues due to an ongoing review of Zadaxin pricing by Chinese authorities, coincident investigations of the company by the SEC and US DOJ, and… More

SCLN VS S&P 500 (SPY)

Fools bullish on SCLN are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about SCLN.

Recs

0
Member Avatar PharmaJoe (< 20) Submitted: 1/4/2017 8:52:07 AM : Outperform Start Price: $10.78 SCLN Score: -7.30

The company is sitting on a large amount of cash relative to their debt and accounts payable. They've also been maintaining consititent net income over the past 5 quarters. The company has novel treatments under development which seem to be very viable. They hold an array of patents and IP's that wont expire for years to come, ensuring a dominant position in the market. They were recently offered to be bought out at a price per share higher that what the stocks currently trading at, indicating strong potential for an upside.

Recs

0
Member Avatar Gilcon (< 20) Submitted: 9/12/2014 8:52:15 AM : Outperform Start Price: $7.38 SCLN Score: +25.67

Research and trials.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 10/28/2013 6:52:12 AM : Underperform Start Price: $4.73 SCLN Score: -92.86

TOS HS pattern

Leaderboard

Find the members with the highest scoring picks in SCLN.

Score Leader

ballout

ballout (< 20) Score: +320.31

The Score Leader is the player with the highest score across all their picks in SCLN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ballout < 20 10/11/2007 Outperform 1Y $2.28 +386.84% +66.53% +320.31 0 Comment
kbgrower < 20 10/10/2007 Outperform NS $2.28 +386.84% +67.48% +319.36 0 Comment
kb9552 < 20 10/9/2006 Outperform 1Y $2.27 +388.99% +96.33% +292.66 0 Comment
rumblinantstanda 65.35 12/1/2009 Outperform 5Y $2.16 +413.89% +124.88% +289.01 0 Comment
rumblinantnodcf 92.97 12/1/2009 Outperform 5Y $2.16 +413.89% +124.88% +289.01 0 Comment
cjhpmh < 20 12/11/2006 Outperform 1Y $2.38 +366.39% +87.21% +279.18 1 Comment
Stvmn 56.22 6/28/2007 Outperform 1Y $2.47 +348.70% +73.95% +274.76 0 Comment
talko17 < 20 9/18/2006 Outperform 1Y $2.35 +372.34% +100.17% +272.17 0 Comment
SmokeyJoeSmokin < 20 12/11/2007 Outperform 5Y $2.52 +340.48% +72.17% +268.31 1 Comment
SEABEE712 22.63 6/28/2007 Outperform 3Y $2.53 +338.74% +74.60% +264.13 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBWS 97.23 7/9/2015 Underperform NS $11.32 -37.28% -6.01% +31.27 9/25/2015 @ $7.10 0 Comment
trackaegiscorp 34.44 7/16/2013 Outperform NS $6.06 +83.17% +48.25% +34.92 0 Comment
TrackPoisedTo < 20 10/2/2012 Outperform 5Y $5.78 +92.04% +72.12% +19.92 0 Comment
TrackBWS 97.23 9/18/2012 Outperform NS $4.72 +85.81% +39.33% +46.48 11/14/2014 @ $8.77 0 Comment
TrackBWS 97.23 4/9/2010 Outperform NS $4.02 -28.11% -5.97% -22.14 8/10/2010 @ $2.89 0 Comment
trackthinkequity 90.60 6/3/2009 Outperform NS $2.26 +391.15% +168.02% +223.13 0 Comment

Featured Broker Partners